LBPSW Projected Dividend Yield
4D Pharma PLC ( OTCBB : LBPSW )4D pharma is a pharmaceutical company. Co. is engaged in the development of a class of drug, Live Biotherapeutic products (LBPs), utilizing the impact of the gut microbiome on human health and disease. Co. has developed MicroRx, its LBP discovery platform. MicroRx interrogates Co.'s library of bacterial isolates for therapeutic functionality and characterizes the bacterial isolates using a range of tools and technologies. Co.'s primary clinical focus areas include immuno-oncology and respiratory disease, with preclinical candidates MRx0029 and MRx0005 targeting central nervous system, MRx0006 targeting rheumatoid arthritis and MRx0002 targeting multiple sclerosis. 21 YEAR PERFORMANCE RESULTS |
LBPSW Dividend History Detail LBPSW Dividend News LBPSW Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |